José Courty Selected Research

OTR4120

7/2010	Toxicological evaluation of RGTA OTR4120, a heparan sulfate mimetic.
12/2007	Effects on coagulation of a synthetic heparan mimetic given intraperitoneally or orally.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

José Courty Research Topics

Disease

37	Neoplasms (Cancer) 07/2022 - 01/2002
6	Pancreatic Neoplasms (Pancreatic Cancer) 10/2021 - 12/2016
4	Adenocarcinoma 10/2021 - 12/2016
4	Breast Neoplasms (Breast Cancer) 05/2020 - 09/2008
4	Glioblastoma (Glioblastoma Multiforme) 01/2018 - 09/2010
4	Neoplasm Metastasis (Metastasis) 12/2016 - 08/2002
3	Prostatic Neoplasms (Prostate Cancer) 10/2016 - 11/2007
3	Carcinogenesis 08/2010 - 08/2002
2	Pathologic Neovascularization 01/2020 - 12/2014
2	Hyperthermia 01/2019 - 05/2015
2	Neuroblastoma 01/2016 - 01/2004
2	Carcinoma (Carcinomatosis) 08/2015 - 01/2004
2	Glioma (Gliomas) 01/2013 - 01/2004
2	Hemorrhage 10/2011 - 12/2007
2	Parkinson Disease (Parkinson's Disease) 08/2011 - 06/2011
2	Infections 01/2011 - 05/2010
1	Blindness (Hysterical Blindness) 01/2020
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2020
1	Macular Degeneration (Age-Related Maculopathy) 01/2020
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2020
1	Vascular Diseases (Vascular Disease) 01/2020
1	Choroidal Neovascularization 01/2020
1	Brain Neoplasms (Brain Tumor) 12/2015
1	Hypertrophy 01/2014
1	Osteoarthritis 07/2013
1	Myocardial Infarction 04/2013
1	Brain Ischemia (Cerebral Ischemia) 04/2013
1	Inflammation (Inflammations) 10/2012
1	Fibrosis (Cirrhosis) 10/2012
1	Wounds and Injuries (Trauma) 10/2012
1	Ulcer 10/2012
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 10/2011
1	Memory Disorders (Memory Loss) 08/2011
1	Cognitive Dysfunction 08/2011

Drug/Important Bio-Agent (IBA)

18	pleiotrophin (HARP)IBA 01/2016 - 08/2002
13	NucleolinIBA 10/2021 - 09/2005
12	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2015 - 01/2002
7	Pharmaceutical PreparationsIBA 07/2022 - 06/2008
7	Peptides (Polypeptides)IBA 05/2021 - 11/2007
7	Heparin (Liquaemin)FDA LinkGeneric 04/2013 - 08/2002
6	LigandsIBA 05/2021 - 06/2010
6	Proteins (Proteins, Gene)FDA Link 01/2018 - 08/2002
3	Gemcitabine FDA Link 01/2019 - 12/2016
3	NucleoproteinsIBA 10/2016 - 05/2011
3	MidkineIBA 01/2016 - 01/2004
2	Biological ProductsIBA 11/2020 - 08/2010
2	Drug CarriersIBA 11/2020 - 02/2020
2	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2020 - 10/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 09/2008
2	NucleophosminIBA 10/2016 - 12/2012
2	InterleukinsIBA 10/2012 - 05/2010
2	CytokinesIBA 10/2012 - 05/2010
2	OTR4120IBA 07/2010 - 12/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2010 - 05/2010
2	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 09/2008 - 08/2002
2	human AZU1 proteinIBA 09/2008 - 11/2007
2	Amino Acids FDA Link 09/2005 - 08/2002
1	MTOR InhibitorsIBA 10/2021
1	CateninsIBA 06/2021
1	AGRO 100IBA 05/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	CollagenIBA 01/2021
1	SaltsIBA 11/2020
1	Silicon Dioxide (Silica)FDA LinkGeneric 11/2020
1	ChitosanIBA 02/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Retinaldehyde (Retinal)IBA 01/2020
1	SaporinsIBA 01/2018
1	Angiopoietin-2IBA 12/2016
1	Biomarkers (Surrogate Marker)IBA 12/2016
1	Docetaxel (Taxotere)FDA Link 10/2016
1	Anaplastic Lymphoma KinaseIBA 01/2016
1	NVP-TAE684IBA 01/2016
1	Phosphotransferases (Kinase)IBA 08/2015
1	Focal Adhesion Protein-Tyrosine KinasesIBA 08/2015
1	Neuropilin-1IBA 08/2015
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 08/2015
1	MitogensIBA 08/2015
1	Therapeutic UsesIBA 05/2015
1	Class 5 Receptor-Like Protein Tyrosine PhosphatasesIBA 07/2013
1	IntegrinsIBA 01/2013
1	Tissue Inhibitor of MetalloproteinasesIBA 12/2012
1	Macrophage Colony-Stimulating FactorIBA 10/2012
1	Ointments (Pastes)IBA 10/2012
1	Interleukin-4 (Interleukin 4)IBA 10/2012
1	Petrolatum (Vaseline)FDA Link 10/2012
1	Caspase 3 (Caspase-3)IBA 01/2012
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2012
1	Bexarotene (LGD1069)FDA Link 10/2011
1	Blood Coagulation Factors (Coagulation Factor)IBA 10/2011
1	Dopamine (Intropin)FDA LinkGeneric 08/2011
1	Death Domain ReceptorsIBA 01/2011
1	Caspase 8 (Caspase-8)IBA 01/2011
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 07/2010

Therapy/Procedure

13	Therapeutics 09/2021 - 06/2008
3	Drug Therapy (Chemotherapy) 05/2021 - 10/2011
1	Immunotherapy 01/2021
1	Microspheres (Microsphere) 11/2020
1	Intraperitoneal Injections 01/2020
1	Radiotherapy 01/2011